Cennerazzo Albert MD is categorized under Internal Medicine Doctors in Springfield, MA and active since 2001.
Cennerazzo Albert MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Albert Cennerazzo at the company’s single location by writing to 3640 Main St # 207, Springfield, Massachusetts MA 01107 or by phoning (413) 739-0669. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cennerazzo Albert MD |
Contact Person: | Albert Cennerazzo |
Address: | 3640 Main St # 207, Springfield, Massachusetts 01107 |
Phone Number: | (413) 739-0669 |
Website Address: | vmaonline.net |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Cennerazzo Albert MD was started in 2001 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Albert Cennerazzo for inquiries that concern Cennerazzo Albert MD by calling the company number (413) 739-0669, as your correspondence is most welcome. Additionally, the physical location of the single location of Cennerazzo Albert MD can be found at the coordinates 42.12703,-72.61128 as well as the street address 3640 Main St # 207 in Springfield, Massachusetts 01107.
For its online presence, you may visit Cennerazzo Albert MD’s website at vmaonline.net and engage with its social media outlets through on Twitter and on Facebook.